Legal Representation
Attorney
Joyce Liou
USPTO Deadlines
Next Deadline
60 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
October 01, 2025
Extension Available
Until October 01, 2025
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 10, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 12, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Mar 12, 2025 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Feb 7, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 7, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 7, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 7, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 1, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 6, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 6, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 17, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 29, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 12, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 12, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 12, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 25, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 25, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 25, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 25, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 14, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 9, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for the treatment of cancer, immunological diseases, metabolic diseases, and neurodegenerative diseases
Class 042
Research and development services in the field of pharmaceuticals
Classification
International Classes
005
042